CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions
Wanghong Hu, Zhenguo Zi, Yanling Jin, Gaoxin Li, Kang Shao, Qiliang Cai, Xiaojing Ma, Fang Wei
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1007/s00262-018-2281-2
- Published
- Dec 6, 2018
- Venue
- Cancer Immunology Immunotherapy
- DOI
- 10.1007/s00262-018-2281-2
- PubMed
- 30523370
- Categories
- CAR-T cell therapy research
- Provenance
- openalex